Nexalin Technology NXL
NASDAQ NXL
$0.33 +0.00 (+0.00%)
At close: Aug 20, 2026 · 1:29 PM UTC

Nexalin Technology (NXL) Cash from Investing Activities Growth (3y) (2026)

Nexalin Technology (NXL) Cash from Investing Activities Growth (3y) (2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Abbott Laboratories 198.81 Bn 193.21 Bn 7.27 Bn 17.83%
2 Stryker 127.76 Bn 124.28 Bn 4.50 Bn -6.23%
3 Medtronic 118.77 Bn 109.55 Bn 6.41 Bn -24.52%
4 Boston Scientific 73.25 Bn 72.71 Bn 3.85 Bn -32.54%
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn -68.12%
6 Dexcom 34.43 Bn 32.49 Bn 830.00 Mn 37.39%
7 GE HealthCare Technologies 33.88 Bn 31.77 Bn 2.18 Bn -11.04%
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn 19.58%
9 Steris 23.11 Bn 22.63 Bn 684.20 Mn -17.67%
10 Nexalin Technology 6.98 Mn 5.97 Mn 8,897.00 18.74%

Historic Data

Download Data
DateValue
Jun 30, 2026 18.74%
Mar 31, 2026 -0.38%